Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Drug:  6,8-bis(benzylthio)octanoic acid
Find trials that include:  Any drugs shown
Results 1-9 of 9 for your search:
Start Over
6,8-Bis(benzylthio)octanoic Acid, Cytarabine, and Daunorubicin Hydrochloride in Treating Older Patients with Newly Diagnosed Acute Myeloid Leukemia
Status: Not yet active
Phase: Phase II, Phase I
Type: Treatment
Age: 60 and over
Trial IDs: CCCWFU 22115, NCI-2015-00890, IRB00033422, NCT02472626
CIP-613, Cytarabine, and Mitoxantrone Hydrochloride in Treating Patients with Relapsed or Refractory Acute Myeloid Leukemia or Granulocytic Sarcoma
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: CCCWFU 22215, NCI-2015-01002, NCT02484391
6,8-bis[benzylthio]octanoic Acid and Combination Chemotherapy in Treating Patients with Metastatic Pancreatic Cancer
Status: Active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Tissue collection/Repository, Treatment
Age: 18 and over
Trial IDs: CCCWFU #57112, NCI-2013-00674, NCT01835041
CPI-613 and Bendamustine Hydrochloride in Treating Patients with Relapsed or Refractory T-Cell Non-Hodgkin Lymphoma or Hodgkin Lymphoma
Status: Active
Phase: Phase I
Type: Treatment
Age: 18 and over
Trial IDs: CCCWFU #28314, NCI-2014-01281, NCT02168140
CPI-613, Bendamustine Hydrochloride, and Rituximab in Treating Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma
Status: Active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: CCCWFU #28114, NCI-2014-01280, NCT02168907
CPI-613 and Fluorouracil in Treating Patients with Metastatic Colorectal Cancer That Cannot Be Removed by Surgery
Status: Active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: CCCWFU #59314, NCI-2014-01779, NCT02232152
6,8-Bis(benzylthio)octanoic Acid in Treating Patients with Advanced or Metastatic Cholangiocarcinoma that Cannot Be Removed by Surgery
Status: Active
Phase: No phase specified
Type: Treatment
Age: 18 to 80
Trial IDs: CCCWFU 59212, NCI-2013-00063, NCT01766219
6,8-bis(Benzylthio)octanoic Acid in Treating Patients with Locally Advanced or Metastatic Pancreatic Cancer
Status: Active
Phase: No phase specified
Type: Treatment
Age: 18 and over
Trial IDs: CCCWFU 57113, NCI-2013-00838, NCT01839981
CPI-613 in Treating Patients with Myelodysplastic Syndromes Who Failed Previous Therapy
Status: Active
Phase: No phase specified
Type: Treatment
Age: 18 and over
Trial IDs: CCCWFU #29113, NCI-2013-01312, 29113, NCT01902381
Start Over